Plexpress Overview

  • Founded
  • 2007
  • Status
  • Acquired/​Merged
  • Employees
  • 2
  • Latest Deal Type
  • M&A

Plexpress General Information


Developer of novel gene expression analysis systems. The company is developing and marketing novel gene expression analysis assay called TRAC which helps to serve a range of applications and experimental systems, including ADME-Tox screening and disease research. Plexpress was established as a spinoff from the Finnish Technology Research Center (VTT) in 2007.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Primary Office
  • Viikinkaari 6
  • 00790 Helsinki
  • Finland
+358 050 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Plexpress Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 00.000 Completed Startup
3. Early Stage VC 26-Apr-2013 00000 00.000 Completed Startup
2. Early Stage VC 18-Apr-2012 $2.3M $5.05M Completed Startup
1. Seed Round 12-May-2009 $2.75M $2.75M Completed Startup
To view Plexpress’s complete valuation and funding history, request access »

Plexpress Board Members (6)

Name Representing Role Since
Auvo Kaikkonen Ph.D Self Board Member 000 0000
You’re viewing 1 of 6 board members. Get the full list »

Plexpress Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Plexpress Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Conor Venture Partners Venture Capital Minority 000 0000 000000 0
Finnvera Venture Capital Minority 000 0000 000000 0
Tekes Not-For-Profit Venture Capital Minority 000 0000 000000 0
University of Helsinki Endowment Limited Partner Minority 000 0000 000000 0
VTT Ventures Corporate Venture Capital Minority 000 0000 000000 0
To view Plexpress’s complete investors history, request access »